Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04755764 · ClinicalTrials.gov registry record
Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy
A clinical trial of Pregnancy Related and Cardiac Output, Low, sponsored by Marshall University.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT04755764 is a study of Pregnancy Related and Cardiac Output, Low that is actively recruiting participants, run by Marshall University. The registered enrollment target is 60 participants, below the 1,962-participant average among 99 other Pregnancy Related trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04755764, a study of Pregnancy Related and Cardiac Output, Low, is actively recruiting participants, sponsored by Marshall University.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research is to characterize the effect of labetalol, atenolol, and nifedipine on maternal hemodynamics early in pregnancy. Patients will be given medication based on their hemodynamics and asked to return for a repeat measurement.
Conditions Studied
Interventions
- DRUG Labetalol
- DRUG Atenolol
- DRUG Nifedipine
Study Locations (1)
West Virginia
- Maternal Hypertension Center at Cabell Huntington Hospital - Huntington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-03-03 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04755764
The ClinicalTrials.gov registry entry for NCT04755764 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,962-participant average among 99 other Pregnancy Related trials with a reported enrollment target (97% lower). The listed sponsor is Marshall University, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 3 interventions - of which Labetalol is the first listed.
NCT04755764 reports 1 study location spanning 1 distinct geographic area - top geographies include West Virginia.
Frequently Asked Questions
What is clinical trial NCT04755764 about?
NCT04755764 is a clinical study titled "Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy". The purpose of the research is to characterize the effect of labetalol, atenolol, and nifedipine on maternal hemodynamics early in pregnancy. Patients will be given medication based on their hemodynamics and asked to return for a repeat measurement.
What is the current status of trial NCT04755764?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2021-03-03. Estimated completion is 2025-12.
What conditions does trial NCT04755764 study?
This clinical trial studies the following conditions: Pregnancy Related, Cardiac Output, Low, Systolic Hypertension, Diastolic Hypertension, Cardiac Output, High.
What interventions are being tested in trial NCT04755764?
The interventions under investigation include: Labetalol (DRUG), Atenolol (DRUG), Nifedipine (DRUG).
Who is sponsoring clinical trial NCT04755764?
This trial is sponsored by Marshall University, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04755764 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Antenatal Support for Iron Deficiency Anemia
RECRUITING · Phase 4
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.